-
Q&A with Dr Chelsee Jensen: FDA Policy Shifts, Biosimilar Development Hurdles, and Market Access in 2026
03 Feb 2026 03:23 GMT
… senior pharmacy specialist and pharmaceutical formulary manager at Mayo … on those in human trials and therefore reduce … denosumab is predominantly a medical benefit drug, though there might … coming out, like omalizumab, Xolair biosimilars, natalizumab, and …
-
Bipartisan Funding Deal Reaches Senate Vote as Partial Shutdown Approaches; CMS Releases Final Rule on Medicaid Waiver of Uniform Tax Requirements
02 Feb 2026 21:43 GMT
… Essential Medicine Procurement by Medicare Participating … programs established by pharmaceutical manufacturers, including … drugs require full FDA approval through new drug applications (NDAs) with clinical trial … early intervention, treatment, recovery support, …
-
<![CDATA[CMS Announces Selection of Drugs for Third Cycle of Medicare Drug Price Negotiation Program, Including First-Ever Part B Drugs]]>
29 Jan 2026 23:25 GMT
…
Xeljanz; Xeljanz XR
Xolair
Meanwhile, the drug chosen for renegotiation is … Announces Selection of Drugs for Third Cycle of Medicare Drug Price Negotiation … #47;cms-announces-selection-drugs-third-cycle-medicare-drug-price-negotiation-program-including …
-
<![CDATA[CMS Announces 15 Drugs for Third Cycle of Medicare Drug Price Negotiation Program]]>
28 Jan 2026 20:05 GMT
… of the Medicare Drug Price Negotiation … vedolizumab; Takeda Pharmaceuticals)
Erleada (apalutamide; Janssen Biotech)
Kisqali ( … XR (tofacitinib; Pfizer)
Xolair (omalizumab; Genentech, Novartis … medications such as Januvia (sitagliptin; Merck) for the treatment …
-
From cancer to diabetes drugs, Trump admin picks 15 medications for price revision—check full list, other details here
28 Jan 2026 11:53 GMT
… for skyrocketing prescription drug costs,” Centers for Medicare & Medicaid Services (CMS) administrator … oral pill used to treat rheumatoid arthritis and ulcerative colitis.
Xolair: An …
Xolair
$1,077,271,000
40,000
In addition, the diabetes medication …
-
<![CDATA[CSU Educational Pilot Shows Drug Access a Major Hurdle]]>
31 Jan 2026 04:07 GMT
… s Miller School of Medicine, and colleagues said the … since the FDA approved the targeted biologic omalizumab (Xolair) to … to-date with the latest treatment guidelines, diagnostic criteria, … allergies,’ resulting in delayed treatment and heavy reliance on peer …
-
Medicare to Negotiate Lower Prices for Botox and Other Drugs
30 Jan 2026 22:29 GMT
… and Lenvima (several cancers)
Autoimmune treatments: Cimzia (Crohn's disease … and Xolair (asthma and allergies)
Botox is included for its medical applications … Centers for Medicare and Medicaid Services has more on the Medicare Drug Price Negotiation …
-
Medicare to negotiate prices on 15 of the most expensive medications
30 Jan 2026 14:29 GMT
… to include high-cost medications administered in doctors’ offices and hospitals, marking … and the pharmaceutical industry by granting Medicare, the world’s largest drug purchaser … chronic migraines and muscle spasms
Xolair for asthma
Between November 2024 …
-
<![CDATA[3 insights from the third set of drugs for Medicare price negotiations]]>
28 Jan 2026 20:49 GMT
… which Part B drugs, which cover outpatient care and doctors’ services, … developments dramatically altered which drugs qualify for Medicare price negotiations. First, … , rheumatoid arthritis, ulcerative colitis
Xolair, asthma, chronic spontaneous urticaria
-
<![CDATA[Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations]]>
29 Jan 2026 03:12 GMT
… prices of drugs directly with pharmaceutical companies.3 … Pfizer Inc.)
Omalizumab (Xolair; Genentech)
Patients are … quality-of-life treatments, such as those … #47;medicare-prescription-drug-affordability/overview/medicare-drug-price-negotiation …